Clinical trials show that high-dose rifampicin markedly increases central nervous system (CNS) exposure in tuberculous meningitis without improving survival. To explain this discrepancy, we develop...
<p><strong>Tác giả:</strong> Aytekin Enver</p>
<p>Clinical trials show that high-dose rifampicin markedly increases central nervous system (CNS) exposure in tuberculous meningitis without improving survival. To explain this discrepancy, we develop a coupled reaction--diffusion--pharmacokinetic/pharmacodynamic (PK/PD) model integrating spatial dynamics of \textit{Mycobacterium tuberculosis}, rifampicin transport across the blood--CNS interface, immune activation with steroid-induced suppression, and drug-induced hepatotoxicity. A threshold fu...</p>
<p>📄 DOI: <a href="https://doi.org/https://doi.org/10.59292/bulletinbiomath.1850950" target="_blank" rel="noopener">https://doi.org/10.59292/bulletinbiomath.1850950</a></p>
<p>📖 <a href="https://doi.org/https://doi.org/10.59292/bulletinbiomath.1850950" target="_blank" rel="noopener">Xem bài báo đầy đủ</a></p>
Bài viết được biên soạn lại bởi LIFVietnam. Nguồn tham khảo: OpenAlex
